
Opinion|Videos|May 28, 2024
Hepatic Encephalopathy: Critical Insights and Closing Thoughts
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Building a Unified Approach to Cardio Kidney Metabolic Health
2
Integrating Combination Therapies for Type 2 Diabetes and CKD
3
Frequent Continuous Glucose Monitoring Linked to Greater HbA1C Reductions in Adults With T2D
4
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
5














































































































































































































